Ireland Colin Edwards, CEO of Merlin Consulting, a consulting firm providing services to the pharma, life sciences and digital health sectors in Ireland, discusses his reasons for leaving Boehringer Ingelheim to set up the company, his thoughts on the digital health landscape in Ireland, and the challenges that he foresees. We…
Slovakia Novartis Slovakia’s Marianthi Psaha discusses the upcoming shift in Slovakia’s healthcare landscape, the importance of a healthy dialogue between the public and private sectors, and the responsibility of the pharma industry to continuously strive for the highest standards of compliance, integrity and performance. You have been Country President for Slovakia…
Singapore Motivated by the transformative role of big data in healthcare, founder and CEO of Vishuo Biomedical, Dongliang Guo discusses the inspiration behind the company, the successful path to commercialization, as well as leveraging Singapore’s brand in the biomedical landscape. What was the inspiration for founding Vishuo Biomedical? What was the vision…
Singapore Having recently obtained cGMP from Singapore’s Health Sciences Authority, the founders of PrIME Biologics showcase the role of PrIME Technology in driving plasma self-sufficiency in Asia, while highlighting how this innovative technology is disrupting industry standards of plasma fractionation. Could you please introduce to our international readers the background underlying…
Mexico General Manager of Merck Mexico, Pedro Galvis, showcases the strategic importance of the Mexican affiliate within Merck’s global network and explains the importance of public-private partnerships in enhancing patient access and treatment in emerging markets. “The Mexican affiliate is a strong contributor to the region’s revenues and one of…
Switzerland Daniel Küng, CEO of Switzerland Global Enterprise (S-GE), the Swiss export promotion agency, also responsible for promoting Switzerland as a business location, reveals how the increase in the value of the Swiss Franc has brought Swiss companies to become more innovative when it comes to selling their products abroad; how…
Singapore Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what it takes for pharma companies to truly succeed in modern-day emerging markets. He also elaborates on Mundipharma’s recent decision to…
Switzerland Dr. Othmar Pfannes, founder and CEO of Genedata, a bioinformatics company headquartered in Switzerland delivering enterprise software, data analysis consulting, and business-process analysis services to the life sciences community, reveals some insights into Genedata’s business strategy and how ultimately their mission is to contribute to reducing the costs of drug…
Novartis Dr Ann Aerts, head of the Novartis Foundation, discusses the role the Novartis Foundation plays within low and middle- income countries across the world and how integrating digital health solutions can strengthen health systems and contribute to global health. We at the Novartis Foundation can leverage the expertise of…
Merck Asanga Halangoda, Director of Life Science at Merck Philippines, discusses the company’s impressive recent market performance, the importance of innovation in maintaining product pipeline, and the bright future of the affiliate’s role in the company’s emerging market portfolio. As an introduction to our readers, could you please give us an…
Logistics Carolina Galicia explains how World Courier Mexico has strengthened its leadership position for clinical trials logistics and leveraged its cutting-edge transport and warehousing capacities to better meet the needs of pharmaceutical companies and handle the supply chain management of their high-value, highly specialized commercial products. How has World Courier Mexico…
Pharma André Lüscher of Gilead Switzerland, reveals how the case of Sovaldi demonstrates the challenges for a healthcare system to handle a truly disruptive medical innovation, the knock-on effect on Gilead´s business model, and ensuring that those affected with hepatitis C are able to receive treatment in Switzerland. A lot has…
See our Cookie Privacy Policy Here
